Mats Bemark | Ruth Palmer Labhttps://deploy-preview-3--ruthpalmerlab.netlify.app/author/mats-bemark/Mats BemarkHugo Blox Builder (https://hugoblox.com)en-usTue, 02 Jan 2024 00:00:00 +0000https://deploy-preview-3--ruthpalmerlab.netlify.app/media/icon_hua1ac8766117554d27209418f2eeeba33_52656_512x512_fill_lanczos_center_3.pngMats Bemarkhttps://deploy-preview-3--ruthpalmerlab.netlify.app/author/mats-bemark/ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibitionhttps://deploy-preview-3--ruthpalmerlab.netlify.app/publication/atri2/Tue, 02 Jan 2024 00:00:00 +0000https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/atri2/Patient-associated mutations in Drosophila Alk perturb neuronal differentiation and promote survivalhttps://deploy-preview-3--ruthpalmerlab.netlify.app/publication/dalk_neuronal_diff/Mon, 01 Aug 2022 00:00:00 +0000https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/dalk_neuronal_diff/DamID transcriptional profiling identifies the Snail/Scratch transcription factor Kahuli as an Alk target in the Drosophila visceral mesodermhttps://deploy-preview-3--ruthpalmerlab.netlify.app/publication/damid_kahuli/Wed, 01 Dec 2021 00:00:00 +0000https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/damid_kahuli/Repotrectinib (TPX-0005) effectively reduces growth of ALK-driven neuroblastoma cellshttps://deploy-preview-3--ruthpalmerlab.netlify.app/publication/repotrectinib/Wed, 18 Dec 2019 00:00:00 +0000https://deploy-preview-3--ruthpalmerlab.netlify.app/publication/repotrectinib/